Allogene Therapeutics, Inc. 10-Q filing
Filed 2025-11-06 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001628280-25-050230
- Form type
- 10-Q
- CIK
- 0001737287
- Primary document
- https://www.sec.gov/Archives/edgar/data/1737287/000162828025050230/allo-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Allogene Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $0 | - | - |
| Operating Income | $-166.9M | - | - |
| Net Income | $-152.1M | - | - |
| Eps Basic | -0.7 | - | - |
| Eps Diluted | -0.7 | - | - |
| Cash And Equivalents | $37.8M | - | - |
| Total Assets | $439.8M | - | - |
| Total Liabilities | $124.4M | - | - |
| Shareholders Equity | $315.3M | - | - |
| Operating Cash Flow | $-121.6M | - | - |
| Capital Expenditures | $386,000 | - | - |